Mercury and Mercury-Containing Preparations: History of Use, Clinical Applications, Pharmacology, Toxicology, and Pharmacokinetics in Traditional Chinese Medicine.

Meiling Zhao, Yi Li, Zhang Wang
Author Information
  1. Meiling Zhao: College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  2. Yi Li: College of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  3. Zhang Wang: College of Ethnomedicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

Abstract

Historically, mercury and mercury-containing preparations have been widely used in traditional Chinese medicine and applied in many clinical practices mainly in the form of mercury sulfides. The clinical application, toxicity manifestations, and symptoms of these preparations largely depend on the route of administration and the dosage form. Commonly used mercury-containing medicinal materials and preparations in traditional Chinese medicine include Cinnabar, an excellent medicine for tranquilizing the nerves; Hongsheng Dan and Baijiang Dan, which have antibacterial, anti-inflammatory, promotion of tissue repair and regeneration and other pharmacological effects. Tibetan medicine commonly uses Zaotai and Qishiwei Zhenzhu pills, which have pharmacological effects such as sedation, anti-inflammatory, anti-convulsant, and improvement of cerebral apoplexy. Menggen Wusu Shibawei pills, commonly used in Mongolian traditional medicine, have the muscle growth and astringent effects. In India and Europe, mercury is often used for treating syphilis. This article summarizes the history, clinical application, pharmacology, toxicology, and pharmacokinetics of mercury and mercury-containing preparations in traditional medicines. In terms of clinical application, it provides suggestions for the rational use and safety of mercury-containing drugs in clinical practices and in public health issues. It will further provide a reference for formulation strategies related to mercury risk assessment and management.

Keywords

References

  1. Environ Health. 2005 Oct 03;4:20 [PMID: 16202128]
  2. Int J Low Extrem Wounds. 2019 Jun;18(2):186-191 [PMID: 31111752]
  3. J Pharm Biomed Anal. 2019 Jan 5;162:264-271 [PMID: 30268994]
  4. BMC Oral Health. 2021 May 15;21(1):262 [PMID: 33992107]
  5. Virchows Arch B Cell Pathol. 1976 Nov 24;22(3):173-96 [PMID: 827102]
  6. Zhongguo Zhong Yao Za Zhi. 2012 Mar;37(6):735-8 [PMID: 22715711]
  7. Immunopharmacol Immunotoxicol. 2007;29(3-4):537-48 [PMID: 18075863]
  8. Sci Total Environ. 2018 Sep 1;634:1563-1579 [PMID: 29710654]
  9. J Ethnopharmacol. 2018 Jan 10;210:340-350 [PMID: 28864167]
  10. J Ethnopharmacol. 2020 Jan 30;247:112299 [PMID: 31606537]
  11. Environ Health Perspect. 2002 Feb;110 Suppl 1:11-23 [PMID: 11834460]
  12. Biol Trace Elem Res. 2019 Feb;187(2):341-356 [PMID: 29777524]
  13. Science. 2003 Aug 29;301(5637):1203 [PMID: 12947190]
  14. Int J Environ Res Public Health. 2020 Jan 21;17(3): [PMID: 31973020]
  15. Zhongguo Zhong Yao Za Zhi. 2015 Jun;40(12):2455-60 [PMID: 26591542]
  16. Pediatr Emerg Care. 2019 Oct;35(10):696-699 [PMID: 27977534]
  17. Zhongguo Zhong Yao Za Zhi. 2013 Sep;38(17):2886-8 [PMID: 24380317]
  18. Zhongguo Zhong Yao Za Zhi. 2014 Oct;39(20):4007-12 [PMID: 25751954]
  19. N Engl J Med. 1998 Jun 4;338(23):1672-6 [PMID: 9614258]
  20. Zhongguo Zhong Yao Za Zhi. 2014 May;39(10):1892-6 [PMID: 25282901]
  21. Evid Based Complement Alternat Med. 2021 Nov 11;2021:2251679 [PMID: 34804175]
  22. Zhongguo Zhong Yao Za Zhi. 2014 Jul;39(13):2573-82 [PMID: 25276985]
  23. Evid Based Complement Alternat Med. 2021 Apr 1;2021:5566078 [PMID: 33868437]
  24. Environ Health Perspect. 2005 Oct;113(10):1381-5 [PMID: 16203251]
  25. Am J Emerg Med. 1992 May;10(3):258-61 [PMID: 1316757]
  26. Int J Legal Med. 2019 Mar;133(2):479-481 [PMID: 30178086]
  27. J Environ Public Health. 2012;2012:460508 [PMID: 22235210]
  28. Zhongguo Zhong Yao Za Zhi. 2015 Feb;40(3):506-10 [PMID: 26084178]
  29. Chemosphere. 2020 Apr;245:125586 [PMID: 31881386]
  30. Zhongguo Zhong Yao Za Zhi. 2011 Dec;36(24):3402-5 [PMID: 22368844]
  31. J Ethnopharmacol. 2011 Apr 12;134(3):839-43 [PMID: 21295128]
  32. J Biomed Biotechnol. 2012;2012:831890 [PMID: 22988426]
  33. N Engl J Med. 2003 Oct 30;349(18):1731-7 [PMID: 14585942]
  34. Rev Environ Health. 2005 Jan-Mar;20(1):39-56 [PMID: 15835497]
  35. Am J Transl Res. 2021 Apr 15;13(4):2644-2652 [PMID: 34017424]
  36. Chemosphere. 2019 Mar;218:527-533 [PMID: 30500713]
  37. J Ethnopharmacol. 2012 Feb 15;139(3):822-8 [PMID: 22207210]
  38. Can J Neurol Sci. 2018 Nov;45(6):620-623 [PMID: 30278852]
  39. J Trace Elem Med Biol. 2017 Dec;44:17-25 [PMID: 28965573]
  40. Zhongguo Zhong Yao Za Zhi. 2011 Sep;36(18):2562-6 [PMID: 22256767]
  41. Regul Toxicol Pharmacol. 2016 Jul;78:1-7 [PMID: 27032305]
  42. Zhongguo Zhong Yao Za Zhi. 2017 Apr;42(7):1258-1264 [PMID: 29052383]
  43. Biomed Pharmacother. 2020 Nov;131:110723 [PMID: 33152910]
  44. Rev Environ Contam Toxicol. 2014;229:1-18 [PMID: 24515807]
  45. J Toxicol Sci. 2016;41(6):757-763 [PMID: 27853104]
  46. Zhongguo Zhong Yao Za Zhi. 2015 Jul;40(14):2887-92 [PMID: 26666045]
  47. J Trace Elem Med Biol. 2015;31:188-92 [PMID: 24894443]
  48. Arch Environ Contam Toxicol. 2020 Feb;78(2):267-283 [PMID: 31760438]
  49. J Med Toxicol. 2013 Dec;9(4):347-54 [PMID: 24178900]
  50. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev. 2017 Jan 2;35(1):29-46 [PMID: 28055311]
  51. Nihon Eiseigaku Zasshi. 2018;73(3):258-264 [PMID: 30270289]
  52. Zhongguo Zhong Yao Za Zhi. 2003 Jul;28(7):639-42 [PMID: 15139110]
  53. Regul Toxicol Pharmacol. 2011 Jul;60(2):206-11 [PMID: 21435368]
  54. Am J Chin Med. 2011;39(1):1-13 [PMID: 21213394]
  55. Zhongguo Zhong Yao Za Zhi. 2012 Apr;37(7):1017-22 [PMID: 22792809]
  56. Neurotoxicology. 2012 Jan;33(1):119-26 [PMID: 22206970]
  57. Bioengineered. 2019 Dec;10(1):353-364 [PMID: 31431119]
  58. J Dent Res. 2020 Jul;99(7):763-768 [PMID: 32315245]

Word Cloud

Created with Highcharts 10.0.0mercuryclinicalmercury-containingpreparationsmedicineapplicationusedtraditionalChineseeffectspracticesformDananti-inflammatorypharmacologicalcommonlypillshistorypharmacologytoxicologypharmacokineticsHistoricallywidelyappliedmanymainlysulfidestoxicitymanifestationssymptomslargelydependrouteadministrationdosageCommonlymedicinalmaterialsincludeCinnabarexcellenttranquilizingnervesHongshengBaijiangantibacterialpromotiontissuerepairregenerationTibetanusesZaotaiQishiweiZhenzhusedationanti-convulsantimprovementcerebralapoplexyMenggenWusuShibaweiMongolianmusclegrowthastringentIndiaEuropeoftentreatingsyphilisarticlesummarizesmedicinestermsprovidessuggestionsrationalusesafetydrugspublichealthissueswillprovidereferenceformulationstrategiesrelatedriskassessmentmanagementMercuryMercury-ContainingPreparations:HistoryUseClinicalApplicationsPharmacologyToxicologyPharmacokineticsTraditionalMedicine

Similar Articles

Cited By